Literature DB >> 21643891

The relationship between hypogammaglobulinemia, monoclonal gammopathy of undetermined significance and humoral immunodeficiency: a case series.

Robert Marc Zemble1, Patricia A Takach, Arnold I Levinson.   

Abstract

Hypogammaglobulinemia of the non-monoclonal immunoglobulin heavy chain classes has been reported in monoclonal gammopathy of undetermined significance (MGUS) patients. Whether low polyclonal immunoglobulin levels are associated with impaired specific antibody production and whether they represent a risk factor for the development of recurrent bacterial infections have not been established in this population. We determined the frequency of MGUS in patients referred to a tertiary care clinical immunology ambulatory care practice for evaluation of hypogammaglobulinemia, who were assessed for deficits in specific antibody production and the presence of recurrent infections. Of the 133 patients evaluated for hypogammaglobulinemia, 68 were screened for monoclonal gammopathy and 5 were found to have MGUS. Three had MGUS associated hypogammaglobulinemia in the absence of a defining primary immunodeficiency, one possibly had common variable immunodeficiency, and one had an uncertain diagnosis. Thus, MGUS may be uncovered in patients presenting with hypogammaglobulinemia even in those who lack an elevated serum level of IgG, IgM, or IgA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21643891     DOI: 10.1007/s10875-011-9548-0

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  34 in total

1.  Common variable immunodeficiency: clinical and immunological features of 248 patients.

Authors:  C Cunningham-Rundles; C Bodian
Journal:  Clin Immunol       Date:  1999-07       Impact factor: 3.969

Review 2.  Mechanisms of polyclonal hypogammaglobulinaemia in multiple myeloma (MM).

Authors:  M C Kyrtsonis; A Mouzaki; A Maniatis
Journal:  Med Oncol       Date:  1999-07       Impact factor: 3.064

3.  B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors.

Authors:  A C Rawstron; F E Davies; R G Owen; A English; G Pratt; J A Child; A S Jack; G J Morgan
Journal:  Br J Haematol       Date:  1998-01       Impact factor: 6.998

4.  Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

Authors:  Clara Cesana; Catherine Klersy; Luciana Barbarano; Anna Maria Nosari; Monica Crugnola; Ester Pungolino; Livio Gargantini; Simonetta Granata; Marina Valentini; Enrica Morra
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

5.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

Authors: 
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

6.  Serum transforming growth factor-beta 1 is related to the degree of immunoparesis in patients with multiple myeloma.

Authors:  M C Kyrtsonis; C Repa; G V Dedoussis; A Mouzaki; A Simeonidis; M Stamatelou; A Maniatis
Journal:  Med Oncol       Date:  1998-07       Impact factor: 3.064

7.  Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance.

Authors:  J Blade; A Lopez-Guillermo; C Rozman; F Cervantes; C Salgado; J L Aguilar; J L Vives-Corrons; E Montserrat
Journal:  Br J Haematol       Date:  1992-07       Impact factor: 6.998

8.  The physiopathological significance of benign monoclonal gammopathy: a study of 64 cases.

Authors:  A Carter; I Tatarsky
Journal:  Br J Haematol       Date:  1980-12       Impact factor: 6.998

9.  Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy.

Authors:  L Baldini; A Guffanti; B M Cesana; M Colombi; O Chiorboli; I Damilano; A T Maiolo
Journal:  Blood       Date:  1996-02-01       Impact factor: 22.113

Review 10.  Assessment and clinical interpretation of polysaccharide antibody responses.

Authors:  Kenneth Paris; Ricardo U Sorensen
Journal:  Ann Allergy Asthma Immunol       Date:  2007-11       Impact factor: 6.347

View more
  2 in total

Review 1.  Case report and literature review on Good's syndrome, a form of acquired immunodeficiency associated with thymomas.

Authors:  Mark Henry Joven; Melvin P Palalay; Charlie Y Sonido
Journal:  Hawaii J Med Public Health       Date:  2013-02

2.  A Tale of Two Immunodeficiencies: A Case of Multiple Myeloma Associated with Profound Immune Defect Mimicking Common Variable Immunodeficiency Syndrome.

Authors:  Leonid L Yavorkovsky; Andrew Hope
Journal:  Perm J       Date:  2019-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.